Rande Is . . . HOME Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rande Is who wrote (4906)	4/2/1999 2:54:00 PM
From: Richard Nisbet	Read Replies (1) of 57584

FSON -- Fusion Medical Technologies... ok...called Fusion Medical Technologies...and spoke with a the VP of IR Kerry Price....he called me back!!! Never spoke to anyone before so I'm excited...here you go...some up to date DD on my little biotech..FSON 1. Concern on recent 144 filings -- most of the 144 filing which took place in December were venture funds (expalin someone...) who were looking to take their profits after 5 years...one company sold its entire position...which Kerry thought was great...and another had partial distribution. However, no directors or insiders sold any of their positions..there was a small 3,500 position sold by a director not sure as to why. All other filings were venture funding... 2. *NEWS* Next week there will be a press release discussing a closing on secondary financing of 1.8 million shares which was completed this past Wednesday. Thats why the movement of the stock on Thursday....to settle at 5.5. This secondary financing deal is to help with the future commercialization and manufacturing of Floseal for the European and U.S. markets. 3. Because of this secondary financing deal secured on Wednesday...FSON now has analyst coverage (i forgot to ask who) on the stock. Analyst prediction is profitability early 2002...break even in 2001 4. European approval -- the prediction on this is ''about the end of the second Q'' but could be sooner...production for European markets would commence in September...after the summer doldrums... 5. FDA approval is expected...conservatively to be 4th Q 99. With U.S. distribution to begin in the 1st Q 2000. Last module was sent to the FDA on Feb. 22 '99. Price said they expect a notice from the FDA within a few weeks to confirm all data has been sent and is presently under review by the FDA. Although his opinion is biased...he said the clinical data is excellent (97% success rate in phase III) and the company expects approval shortly...depending on the FDA. Note the FDA is under alot of pressure to approve drugs and devices...thus the new ''speed up modular program'' was insituted...FDA approval could come as early as end 3rd Q but definitely before year is out. 6. Distribution of Floseal -- will be distributed by independent distributors worldwide...Spine? he mentioned...not sure what that means...but news of distributors will hit the PR when European approval comes in...negotiations are continuing. so...thats some of the DD i did today on my day off.. :) I'm excited...this company had me worried there for a bit cause there was no news and it kinda ust went along...please post reactions...I need your critiques so i can get more info... thanks Rande, KZAP, Will, Bishop, GA Bard and Metals for making me actually do something teachers hate to do....HOMEWORK :)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next